Holzbeierlein JM - Search Results

1

Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells.

He C, Duan S, Dong L, Wang Y, Hu Q, Liu C, Forrest ML, Holzbeierlein JM, Han S, Li B. He C, et al. Among authors: holzbeierlein jm. Prostate. 2017 Aug;77(11):1187-1198. doi: 10.1002/pros.23377. Epub 2017 Jun 20. Prostate. 2017. PMID: 28631436 Free PMC article.

2

Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.

Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B. Liao X, et al. Endocrinology. 2003 May;144(5):1656-63. doi: 10.1210/en.2002-0157. Endocrinology. 2003. PMID: 12697668

3

Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.

Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B. Liao X, et al. Endocrinology. 2004 Jun;145(6):2941-9. doi: 10.1210/en.2003-1519. Epub 2004 Feb 26. Endocrinology. 2004. PMID: 14988390

4

Complications of androgen-deprivation therapy for prostate cancer.

Holzbeierlein JM, Castle EP, Thrasher JB. Holzbeierlein JM, et al. Clin Prostate Cancer. 2003 Dec;2(3):147-52. doi: 10.3816/cgc.2003.n.022. Clin Prostate Cancer. 2003. PMID: 15040857 Review.

5

Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells.

Matthews SB, Vielhauer GA, Manthe CA, Chaguturu VK, Szabla K, Matts RL, Donnelly AC, Blagg BS, Holzbeierlein JM. Matthews SB, et al. Among authors: holzbeierlein jm. Prostate. 2010 Jan 1;70(1):27-36. doi: 10.1002/pros.21035. Prostate. 2010. PMID: 19739131 Free PMC article.

6

Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo.

Zhu Q, Yang J, Han S, Liu J, Holzbeierlein J, Thrasher JB, Li B. Zhu Q, et al. Prostate. 2011 Jun 1;71(8):835-45. doi: 10.1002/pros.21300. Epub 2010 Oct 28. Prostate. 2011. PMID: 21456066

7

Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells.

Eskew JD, Sadikot T, Morales P, Duren A, Dunwiddie I, Swink M, Zhang X, Hembruff S, Donnelly A, Rajewski RA, Blagg BS, Manjarrez JR, Matts RL, Holzbeierlein JM, Vielhauer GA. Eskew JD, et al. Among authors: holzbeierlein jm. BMC Cancer. 2011 Oct 31;11:468. doi: 10.1186/1471-2407-11-468. BMC Cancer. 2011. PMID: 22039910 Free PMC article.

8

CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells.

Li C, Xu H, Xiao L, Zhu H, Zhang G, Wei W, Li K, Cao X, Shen D, Holzbeierlein J, Li B. Li C, et al. Cancer Biol Ther. 2018;19(12):1193-1203. doi: 10.1080/15384047.2018.1491507. Epub 2018 Aug 6. Cancer Biol Ther. 2018. PMID: 30081723 Free PMC article.

9

Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.

Li C, He C, Xu Y, Xu H, Tang Y, Chavan H, Duan S, Artigues A, Forrest ML, Krishnamurthy P, Han S, Holzbeierlein JM, Li B. Li C, et al. Among authors: holzbeierlein jm. Prostate. 2019 May;79(6):628-639. doi: 10.1002/pros.23767. Epub 2019 Jan 20. Prostate. 2019. PMID: 30663084 Free PMC article.

10

Xanthine oxidase-mediated oxidative stress promotes cancer cell-specific apoptosis.

Xu H, Li C, Mozziconacci O, Zhu R, Xu Y, Tang Y, Chen R, Huang Y, Holzbeierlein JM, Schöneich C, Huang J, Li B. Xu H, et al. Among authors: holzbeierlein jm. Free Radic Biol Med. 2019 Aug 1;139:70-79. doi: 10.1016/j.freeradbiomed.2019.05.019. Epub 2019 May 16. Free Radic Biol Med. 2019. PMID: 31103463 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page